I K Dev
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Molecular Biology top 10%
- Biochemical and Molecular Research
- RNA and protein synthesis mechanisms
Papers in ⓘ
-
- Amino Acid Enzymes and Metabolism 3
- Oncology 14
- Peptidase Inhibition and Analysis 6
- Colorectal Cancer Treatments and Studies 4
- Co-authors
- Paul H. Ray (11 shared papers)Victoria L. Harvey (5 shared papers)W S Dallas (7 shared papers)Petr Novák (2 shared papers)Richard J. Harvey (2 shared papers)Robert Ferone (10 shared papers)David S. Duch (8 shared papers)Neil L. Spector (1 shared paper)
- Journals
- Journal of Biological Chemistry (11 papers)Journal of Bacteriology (5 papers)Journal of Medicinal Chemistry (5 papers)Antimicrobial Agents and Chemotherapy (2 papers)British Journal of Cancer (1 paper)
- Partner nations
- United StatesNetherlands
In The Last Decade
I K Dev
35 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 89
- Oncology 415
- Molecular Biology 975
- Infectious Diseases 198
- Biotechnology 81
- Genetics 248
Countries citing papers authored by I K Dev
This map shows the geographic impact of I K Dev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I K Dev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I K Dev more than expected).
Fields of papers citing papers by I K Dev
This network shows the impact of papers produced by I K Dev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I K Dev. The network helps show where I K Dev may publish in the future.
Co-authors
The 25 scholars most cited alongside I K Dev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 256 | |
| 2 | 1985 | 98 | |
| 3 | Biochemical and cellular pharmacology of 1843U89, a novel benzoquinazoline inhibitor of thymidylate synthase. | 1993 | 93 |
| 4 | 1992 | 88 | |
| 5 | 1984 | 67 | |
| 6 | 1988 | 63 | |
| 7 | 1991 | 59 | |
| 8 | 1994 | 53 | |
| 9 | 1990 | 50 | |
| 10 | 1978 | 50 | |
| 11 | 1994 | 48 | |
| 12 | 1986 | 47 | |
| 13 | 1993 | 45 | |
| 14 | 1988 | 43 | |
| 15 | 1997 | 42 | |
| 16 | 1992 | 39 | |
| 17 | 2004 | 35 | |
| 18 | 1982 | 35 | |
| 19 | 1990 | 34 | |
| 20 | Metabolic effects and kill of human T-cell leukemia by 5-deazaacyclotetrahydrofolate, a specific inhibitor of glycineamide ribonucleotide transformylase. | 1992 | 34 |
About I K Dev
I K Dev is a scholar working on Biochemistry, Oncology, Rheumatology, Molecular Biology and Clinical Biochemistry, having authored 35 papers that have together received 1.6k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (16 papers), Enzyme Structure and Function (11 papers), Folate and B Vitamins Research (7 papers), Peptidase Inhibition and Analysis (6 papers), Colorectal Cancer Treatments and Studies (4 papers), Quinazolinone synthesis and applications (4 papers), Bacterial Genetics and Biotechnology (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). The work is most often cited by research in Oncology (415 citations), Molecular Biology (975 citations), Infectious Diseases (198 citations), Biotechnology (81 citations) and Genetics (248 citations). I K Dev has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Paul H. Ray, Victoria L. Harvey, W S Dallas, Petr Novák, Richard J. Harvey, Robert Ferone, David S. Duch, Neil L. Spector, Herbert I. Hurwitz and Rakesh Kumar. Their work appears in journals such as Journal of Biological Chemistry, Journal of Bacteriology, Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.